Page last updated: 2024-09-03

pyrroxamycin and substance p

pyrroxamycin has been researched along with substance p in 1 studies

Compound Research Comparison

Studies
(pyrroxamycin)
Trials
(pyrroxamycin)
Recent Studies (post-2010)
(pyrroxamycin)
Studies
(substance p)
Trials
(substance p)
Recent Studies (post-2010) (substance p)
90117,2892772,010

Protein Interaction Comparison

ProteinTaxonomypyrroxamycin (IC50)substance p (IC50)
Substance-P receptorRattus norvegicus (Norway rat)0.0005
Substance-K receptorRattus norvegicus (Norway rat)0.2
Substance-K receptorHomo sapiens (human)0.2455
Substance-P receptorHomo sapiens (human)0.0011
Neuromedin-K receptorHomo sapiens (human)0.125
Substance-K receptorMesocricetus auratus (golden hamster)0.148

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hara, O; Hotta, K; Ishida-Okawara, A; Koyama, M; Masuda, K; Miyadoh, S; Mizuno, S; Suzuki, K1

Other Studies

1 other study(ies) available for pyrroxamycin and substance p

ArticleYear
Pyrrolomycin group antibiotics inhibit substance P-induced release of myeloperoxidase from human polymorphonuclear leukocytes.
    The Journal of antibiotics, 1991, Volume: 44, Issue:5

    Topics: Actinomycetales; Anti-Bacterial Agents; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Neutrophils; Peroxidase; Pyrroles; Substance P

1991